On March 6, 2023, Transcarent, a health and care experience company that makes it easy for people to access high-quality, affordable care, announced plans to acquire an AI-powered virtual care platform and on-demand primary care business from 98point6. The acquisition will give Transcarent access to 98point6’s technology and an affiliated medical group of providers skilled at delivering high-quality, on-demand care.
Transcarent co-founder and CEO Glen Tullman says the deal is worth up to $100 million and puts “AI front and center.” The idea behind Transcarent is to reduce the bureaucratic inefficiency of finding doctors and getting high quality care with a one-stop shop. The platform lets users talk to a primary care doctor and order prescriptions through an app and it helps them set up in-home care. It can also shepherd them through surgeries or complex care, such as cancer treatment.
The transaction is expected to close March 31, 2023, after which 98point6 Technologies will continue to develop innovative technology solutions and focus its efforts on licensing its 98point6 Technology Platform software to third-party health care providers.
Wilson Sonsini Goodrich & Rosati is representing Transcarent in the transaction. The team includes:
M&A
Rich Mullen
Esther Lukman
Joy-Annette Atsegbua
Nour Berbari
Corporate
Mark Baudler
Lianna Whittleton
Angela Loc
Lindsey Berger
Technology Transactions
Chris Paniewski
Dena Smith
Allegra Sachs
Barclay Oudersluys
Emily Chan
Kristin Bradley
Christopher Murray
Waen Vejjajiva
Privacy and Data Security
Matt Staples
Haley Bavasi
Daniel Chen
Hale Melnick
Michael O’Brien
Diya Jajal
Employee Benefits
Sriram Krishnamurthy
Matthew Norgard
Jason Chan
Employment
Matt Gorman
Neil Gulyako
FDA Regulatory
Eva Yin
National Security
Anne Seymour
Tarek Helou
Seth Cowell
Nicholas Hakun
For more information, please see Transcarent's press release. Further coverage can be found on Forbes.